We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/fmb-2022-0278

Background: Developing an effective treatment for fungal infections is among contemporary medicine's challenges. In this study we aimed to eradicate mannan in pathogenic Candidae's cell walls using a nontoxic method, mannanase. Materials & Methods: We investigated the in vitro antifungal activities of mannanase immobilized on zinc oxide nanoparticles (ZnONps) and reduced graphene oxide nanoparticles (RGONps), as well as therapeutics against Candidae. Mannanase was purified from Bacillus invictae (activity: 5.15 EU/ml; range: 60–80%) and then immobilized it to ZnO and RGO to enhance its effectiveness. Results: Mannanase immobilized on ZnONps had the highest activity, with a value of 4.97 EU/ml, more effective than amphotericin-B. However, it could not reach the inhibition rates of other antifungals. Conclusion: Mannanase immobilized on ZnONps could be an effective fungicide for Candida biocontrol.

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

  • 1. Francois M, Snoeckx E, Putteman P et al. A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole. AAPS Pharm. Sci. 5(1), E5 (2003).
  • 2. Anh DN, Hung DN, Tien TV et al. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infect. Dis. 21(1), 523 (2021). • Interesting article on the prevalence and antifungal susceptibility of Candida albicans.
  • 3. Johal HS, Garg T, Rath G, Goyal AK. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 23(2), 550–563 (2016).
  • 4. Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur. J. Obstet. Gynecol. Reprod. Biol. 126(1), 121–125 (2006).
  • 5. Smagulova AA, Khismetova ZA, Kamaliyeva AK, Sagcatbek NS. Bacterial vaginosis and desquamative inflammatory vaginitis: choice of an effective therapy method. Review. Science Healthcare 24(4), 216–223 (2022).
  • 6. Zullo MA, Schiavi MC, Di Pinto A et al. Efficacy and safety of oral administration of a product based on hydroxytyrosol as preventive therapy for recurrent vulvo-vaginal candidosis: a prospective observational pilot study. Eur. Rev. Med. Pharmacol. Sci. 24(13), 7427–7432 (2020).
  • 7. Yadav LK, Yadav RL. Prevalence of vaginal yeast infections in pregnant and non-pregnant women attending at Gynecology and Obstetrics Department of the tertiary care center in Central region of Nepal. Microbe. Infect. Dis. 4(1), 225–230 (2022).
  • 8. Li H, Yang J, Zhang X, Xu X, Song F, Li H. Biocontrol of Candida albicans by antagonistic microorganisms and bioactive compounds. Antibiotics (Basel) 11(9), 1238 (2022).
  • 9. Peyclit L, Yousfi H, Rolain JM, Bittar F. Drug repurposing in medical mycology: identification of compounds as potential antifungals to overcome the emergence of multidrug-resistant fungi. Pharmaceuticals (Basel) 14(5), 488 (2021).
  • 10. Fang J, Huang B, Ding Z. Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis. J. Prosthet. Dent. 125(2), 257–265 (2021).
  • 11. Wijnants S, Vreys J, Van Dijck P. Interesting antifungal drug targets in the central metabolism of Candida albicans. Trends Pharmacol Sci 43(1), 69–79 (2022).
  • 12. Kantarcıoğlu AS, Yücel A. Mannan in Candida albicans: Various properties and importance. Cerrahpasa Med J 35(1), 1–11 (2014).
  • 13. Afolabi FT, Jimoh YZ. Production, purification and characterization of mannanase obtained from Pichia kudriavzevii strain AUMC 10190 isolated from citrus wastes. World News Nat. Sci. 45, 1–17 (2022).
  • 14. Dawood A, Ma K. Applications of microbial beta-mannanases. Front. Bioeng. Biotechnol. 8, 598630 (2020).
  • 15. David A, Singh Chauhan P, Kumar A et al. Coproduction of protease and mannanase from Bacillus nealsonii PN-11 in solid state fermentation and their combined application as detergent additives. Int. J. Biol. Macromol. 108, 1176–1184 (2018).
  • 16. Ge JP, Du RP, Zhao D, Song G, Jin M, Ping WX. Bio-chemical characterization of a β-mannanase from Bacillus licheniformis HDYM-04 isolated from flax water-retting liquid and its decolorization ability of dyes. RSC Adv. 6(28), 23612–23621 (2016).
  • 17. Norizan N, Halim M, Tan JS et al. Enhancement of beta-mannanase production by Bacillus subtilis ATCC11774 through optimization of medium composition. Molecules 25(15), 3516 (2020).
  • 18. Sun Y, Zhou X, Zhang W, Tian X, Ping W, Ge J. Enhanced beta-mannanase production by Bacillus licheniformis by optimizing carbon source and feeding regimes. Prep. Biochem. Biotechnol. 52(7), 845–853 (2022).
  • 19. Zang H, Xie S, Wu H et al. A novel thermostable GH5_7 beta-mannanase from Bacillus pumilus GBSW19 and its application in manno-oligosaccharides (MOS) production. Enzyme Microb. Technol. 78, 1–9 (2015).
  • 20. Zhou C, Xue Y, Ma Y. Characterization and high-efficiency secreted expression in Bacillus subtilis of a thermo-alkaline beta-mannanase from an alkaliphilic Bacillus clausii strain S10. Microb. Cell Fact 17(1), 124 (2018).
  • 21. Hassan ME, Yang Q, Xiao Z et al. Impact of immobilization technology in industrial and pharmaceutical applications. 3 Biotech 9(12), 440 (2019).
  • 22. Wang L, Guan S, Bai J et al. Enzyme immobilized in BioMOFs: facile synthesis and improved catalytic performance. Int. J. Biol. Macromol. 144, 19–28 (2020).
  • 23. Dikbas N, Ucar S, Tozlu G, Oznuluer Ozer T, Kotan R. Bacterial chitinase biochemical properties, immobilization on zinc oxide (ZnO) nanoparticle and its effect on Sitophilus zeamais as a potential insecticide. World J. Microbiol. Biotechnol. 37(10), 173 (2021).
  • 24. Faizan M, Faraz A, Mir AR, Hayat S. Role of zinc oxide nanoparticles in countering negative effects generated by cadmium in Lycopersicon esculentum. J. Plant Growth Regulat. 40(1), 101–115 (2021).
  • 25. Isanapong J, Pornwongthong P. Immobilized laccase on zinc oxide nanoarray for catalytic degradation of tertiary butyl alcohol. J. Hazard. Mater. 411, 125104 (2021).
  • 26. Espitia PJP, Soares NFF, Coimbra JSR, De Andrade NJ, Cruz RS, Medeiros EaA. Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications. Food Bioprocess. Technol. 5(5), 1447–1464 (2012).
  • 27. Işık K. In vitro evaluation of effects of different properties of ZnO nanoparticles on fibroblast cell. Anadolu University (2010).
  • 28. Adeel M, Bilal M, Rasheed T, Sharma A, Iqbal HMN. Graphene and graphene oxide: functionalization and nano-bio-catalytic system for enzyme immobilization and biotechnological perspective. Int. J. Biol. Macromol. 120(Pt B), 1430–1440 (2018).
  • 29. Kumar R, Pal P. Lipase immobilized graphene oxide biocatalyst assisted enzymatic transesterification of Pongamia pinnata (Karanja) oil and downstream enrichment of biodiesel by solar-driven direct contact membrane distillation followed by ultrafiltration. Fuel Process. Technol. 211, 106577 (2020).
  • 30. Kalpana VN, Devi Rajeswari V. A review on green synthesis, biomedical applications, and toxicity studies of ZnO NPs. Bioinorg. Chem. Appl. 2018, 3569758 (2018).
  • 31. Bahri S, Sundu B, Aprianto MR. Mannanase activity produced through fermentation of coconut flour at various pH by Aspergilus niger. J. Phys. 1242, 012009 (2019).
  • 32. Ahamed M, Javed Akhtar M, Majeed Khan MA, Alhadlaq HA. Facile green synthesis of ZnO-RGO nanocomposites with enhanced anticancer efficacy. Methods 199, 28–36 (2022). •• Important paper describing how the green synthesis of ZnO-RGO nanoparticles was performed.
  • 33. Preety Hooda V. Immobilization and kinetics of catalase on calcium carbonate nanoparticles attached epoxy support. Appl. Biochem. Biotechnol. 172(1), 115–130 (2014).
  • 34. Preety Hooda V. A novel polyurethane/nano ZnO matrix for immobilization of chitinolytic enzymes and optical sensing of chitin. Int. J. Biol. Macromol. 106, 1173–1183 (2018).
  • 35. Kasthuri N, Hayworth K, Lichtman J, Erdman N, Ackerley CA. New technique for ultra-thin serial brain section imaging using scanning electron microscopy. Microscopy Microanalysis 13(S02), 26–27 (2007).
  • 36. Micheva KD, Smith SJ. Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron 55(1), 25–36 (2007).
  • 37. Lozano-Chiu M, Nelson PW, Paetznick VL, Rex JH. Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991. J. Clin. Microbiol. 37(5), 1625–1627 (1999).
  • 38. Giri S, Kindo AJ. Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method. Indian J. Pathol. Microbiol 57(4), 595–597 (2014). •• Very important article describing the evaluation of antifungal organism tests in Candida isolates by Candifast and disk diffusion method.
  • 39. Ahmad R, Sardar M. Enzyme immobilization: an overview on nanoparticles as immobilization matrix. Biochem. Analyt. Biochem. 4(3), 178 (2015).
  • 40. Wu J, Chen T, Luo X, Han D, Wang Z, Wu J. TG/FTIR analysis on co-pyrolysis behavior of PE, PVC and PS. Waste Manag. 34(3), 676–682 (2014).
  • 41. Nagaraju G, Prashanth SA, Shastri M, Yathish KV, Anupama C, Rangappa DJMRB. Electrochemical heavy metal detection, photocatalytic, photoluminescence, biodiesel production and antibacterial activities of Ag–ZnO nanomaterial. Mater. Res. Bull. 94, 54–63 (2017).
  • 42. Sharma N, Sharma V, Sharma SK, Sachdev K. Gas sensing behaviour of green synthesized reduced graphene oxide (rGO) for H2 and NO. Mater Lett 236, 444–447 (2019).
  • 43. Nunnally NS, Damm T, Lockhart SR, Berkow EL. Categorizing susceptibility of clinical isolates of Candida auris to amphotericin B, caspofungin, and fluconazole by use of the CLSI M44-A2 disk diffusion method. J. Clin. Microbiol. 59(4), e02355-20 (2021).
  • 44. Chavez-Esquivel G, Cervantes-Cuevas H, Ybieta-Olvera LF, Castaneda Briones MT, Acosta D, Cabello J. Antimicrobial activity of graphite oxide doped with silver against Bacillus subtilis, Candida albicans, Escherichia coli, and Staphylococcus aureus by agar well diffusion test: synthesis and characterization. Mater. Sci. Eng. C. Mater. Biol. Appl. 123, 111934 (2021).
  • 45. Coutinho TC, Tardioli PW, Farinas CS. Phytase immobilization on hydroxyapatite nanoparticles improves its properties for use in animal feed. Appl. Biochem. Biotechnol. 190(1), 270–292 (2020).
  • 46. Dhiman S, Srivastava B, Singh G, Khatri M, Arya SK. Immobilization of mannanase on sodium alginate-grafted-beta-cyclodextrin: an easy and cost effective approach for the improvement of enzyme properties. Int. J. Biol. Macromol. 156, 1347–1358 (2020).
  • 47. Mohapatra BR. Characterization of β-mannanase extracted from a novel Streptomyces species Alg-S25 immobilized on chitosan nanoparticles. Biotechnol. Biotechnol. Equip. 35(1), 150–161 (2021). • An interesting article in terms of immobilization of mannanase.
  • 48. Naghshbandi MP, Moghimi H, Latif B. Covalent immobilization of phytase on the multi-walled carbon nanotubes via diimide-activated amidation: structural and stability study. Artif. Cells Nanomed. Biotechnol. 46(sup1), 763–772 (2018).
  • 49. Obayomi KS, Lau SY, Danquah M, Chiong T, Takeo M. Advances in graphene oxide based nanobiocatalytic technology for wastewater treatment. Environment. Nanotechnol. Monit. Manag. 17, 100647 (2022).
  • 50. Zhou W, Rao Y, Zhuang W et al. Improved enzymatic activity by oriented immobilization on graphene oxide with tunable surface heterogeneity. Composites Part B: Eng. 216, 108788 (2021).
  • 51. Pavlova IN, Tin'ianova NZ. [Isolation and characterization of microorganisms with mannanase activity]. Prikl. Biokhim. Mikrobiol. 16(4), 578–583 (1980).
  • 52. Joshi KM, Shelar A, Kasabe U et al. Biofilm inhibition in Candida albicans with biogenic hierarchical zinc-oxide nanoparticles. Biomater. Adv. 134, 112592 (2022).
  • 53. Padmavathi AR, P SM, Das A et al. Impediment to growth and yeast-to-hyphae transition in Candida albicans by copper oxide nanoparticles. Biofouling 36(1), 56–72 (2020).
  • 54. Panacek A, Kolar M, Vecerova R et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 30(31), 6333–6340 (2009).
  • 55. Soliman GM. Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int. J. Pharm. 523(1), 15–32 (2017).
  • 56. Mirchandani Y, Patravale VB, S B. Solid lipid nanoparticles for hydrophilic drugs. J. Control. Release 335, 457–464 (2021).
  • 57. Radwan MA, Al Quadeib BT, Siller L, Wright MC, Horrocks B. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.. Drug Deliv. 24(1), 40–50 (2017).